TAJANA, Gianfranco
TAJANA, Gianfranco
Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
A new biopsy technique to investigate Peyronie's disease associated histologicalterations: results with two different forms of therapy.
2002-01-01 Mirone, V; Imbimbo, C; Palmieri, A; Longo, N; Fusco, F; Tajana, Gianfranco
A standardized procedure for using human corpus cavernosum strips to evaluatedrug activity.
2000-01-01 Mirone, V; Sorrentino, R; DI VILLA BIANCA, R; Imbimbo, C; Palmieri, A; Fusco, F; Tajana, Gianfranco; Cirino, G.
ANTISEPSI NATURALE
2007-01-01 Tajana, Gianfranco
c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges incancer and cardiovascular diseases
2003-01-01 DE NIGRIS, F; Sica, V; Herrmann, J; Condorelli, G; Chade, Ar; Tajana, Gianfranco; Lerman, A; Lerman, Lo; Napoli, C.
Clinical Pathophysiology and Molecular Biology of the Urothelium and the GAG layer
2012-01-01 Tajana, Gianfranco; Mauro, Cervigni
Evidence that protease activated receptor 2 expression is enhanced in humancoronary atherosclerotic lesions
2004-01-01 Napoli, C; DE NIGRIS, F; Wallace, Jl; Hollenberg, Md; Tajana, Gianfranco; DE ROSA, G; Sica, V; Cirino, G.
Glycoxidation of low-density lipoprotein increases TUNEL positivity and CPP32activation in human coronary cells
2003-01-01 DE NIGRIS, F; Tajana, Gianfranco; Condorelli, M; D'Armiento, Fp; Sica, G; Lerman, Lo; Napoli, C.
In the Huh7 Hepatoma Cells Diclofenac and Indonethacin Activate Differently the Unfolded Protein Response and Induce ER Stress Apoptosis
2011-01-01 Franceschelli, Silvia; Moltedo, Ornella; Amodio, Giuseppina; Tajana, Gianfranco; Remondelli, Paolo
Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but notNO-dependent mechanisms in human corpus cavernosum function
2003-01-01 Cirino, G; Sorrentino, R; DI VILLA BIANCA, R; Popolo, Ada; Palmieri, A; Imbimbo, C; Fusco, F; Longo, N; Tajana, Gianfranco; Ignarro, Lj; Mirone, V.
ISTOLOGIA
2008-01-01 Caputo, G; Casali, A; Colombo, R; DE SIMONE, I; Gargiulo, G; Guidotti, L; Maraldi, N; Millo, R; Rizzotti, M; Rosati, P; Tajana, Gianfranco; Tessitote, V; Urzi', F.
Microarray analysis: a novel research tool for cardiovascular scientists andphysicians.
2003-01-01 Napoli, C; Lerman, Lo; Sica, V; Lerman, A; Tajana, Gianfranco; DE NIGRIS, F.
Nitric oxide induced Endoplasmic Reticulum Stress activates the expression of cargo receptor proteins and alters the glycoprotein transport to the Golgi complex
2006-01-01 Renna, Maurizio; Bonatti, S; DE STEFANO, D; Carnuccio, R; Tajana, Gianfranco; Remondelli, Paolo
Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis inrat carrageenin-sponge implant model
2004-01-01 Maiuri, Mc; Tajana, Gianfranco; Iuvone, T; DE STEFANO, D; Mele, G; Ribecco, Mt; Cinelli, Mp; Romano, Mf; Turco, Maria Caterina; Carnuccio, R.
Promotion of behavioural change in people with hypertension: an interventionstudy.
2008-01-01 Scala, D; D'Avino, M; Cozzolino, S; Mancini, A; Andria, B; Caruso, G; Tajana, Gianfranco; Caruso, D.
Protective role of nuclear factor kappa B against nitric oxide-induced apoptosis in J774 macrophages.
2001-01-01 D'Acquisto, F; DE CRISTOFARO, F; Maiuri, Mc; Tajana, Gianfranco; Carnuccio, R.
RUOLO DELL'ACIDO IALURONICO
1999-01-01 Tajana, Gianfranco
SISTEMA ERITROPOIETINA: LA REGOLAZIONE DEL LIFESPAN
2005-01-01 Tajana, Gianfranco
The immunomodulatory protein SV-IV protects serum-deprived cells againstapoptosis but not against G0/G1 arrest: possible implications for the survival ofimplanting embryo.
2007-01-01 Morelli, F; Peluso, G; Petillo, O; Giannattasio, A; Filosa, S; Motta, Cm; Tammaro, S; Zatterale, A; Calzone, R; Budillon, A; Cartenì, M; DE MARIA, S; Costanza, Mr; Nigro, A; Petrazzuolo, M; Buommino, E; Rizzo, M; Capasso, G; Baiano, S; Moscatiello, F; Ravagnan, G; Fuggetta, Mp; Tajana, Gianfranco; Stiuso, P; Metafora, Bm; Metafora, V; Metafora, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A new biopsy technique to investigate Peyronie's disease associated histologicalterations: results with two different forms of therapy. | 1-gen-2002 | Mirone, V; Imbimbo, C; Palmieri, A; Longo, N; Fusco, F; Tajana, Gianfranco | |
| A standardized procedure for using human corpus cavernosum strips to evaluatedrug activity. | 1-gen-2000 | Mirone, V; Sorrentino, R; DI VILLA BIANCA, R; Imbimbo, C; Palmieri, A; Fusco, F; Tajana, Gianfranco; Cirino, G. | |
| ANTISEPSI NATURALE | 1-gen-2007 | Tajana, Gianfranco | |
| c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges incancer and cardiovascular diseases | 1-gen-2003 | DE NIGRIS, F; Sica, V; Herrmann, J; Condorelli, G; Chade, Ar; Tajana, Gianfranco; Lerman, A; Lerman, Lo; Napoli, C. | |
| Clinical Pathophysiology and Molecular Biology of the Urothelium and the GAG layer | 1-gen-2012 | Tajana, Gianfranco; Mauro, Cervigni | |
| Evidence that protease activated receptor 2 expression is enhanced in humancoronary atherosclerotic lesions | 1-gen-2004 | Napoli, C; DE NIGRIS, F; Wallace, Jl; Hollenberg, Md; Tajana, Gianfranco; DE ROSA, G; Sica, V; Cirino, G. | |
| Glycoxidation of low-density lipoprotein increases TUNEL positivity and CPP32activation in human coronary cells | 1-gen-2003 | DE NIGRIS, F; Tajana, Gianfranco; Condorelli, M; D'Armiento, Fp; Sica, G; Lerman, Lo; Napoli, C. | |
| In the Huh7 Hepatoma Cells Diclofenac and Indonethacin Activate Differently the Unfolded Protein Response and Induce ER Stress Apoptosis | 1-gen-2011 | Franceschelli, Silvia; Moltedo, Ornella; Amodio, Giuseppina; Tajana, Gianfranco; Remondelli, Paolo | |
| Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but notNO-dependent mechanisms in human corpus cavernosum function | 1-gen-2003 | Cirino, G; Sorrentino, R; DI VILLA BIANCA, R; Popolo, Ada; Palmieri, A; Imbimbo, C; Fusco, F; Longo, N; Tajana, Gianfranco; Ignarro, Lj; Mirone, V. | |
| ISTOLOGIA | 1-gen-2008 | Caputo, G; Casali, A; Colombo, R; DE SIMONE, I; Gargiulo, G; Guidotti, L; Maraldi, N; Millo, R; Rizzotti, M; Rosati, P; Tajana, Gianfranco; Tessitote, V; Urzi', F. | |
| Microarray analysis: a novel research tool for cardiovascular scientists andphysicians. | 1-gen-2003 | Napoli, C; Lerman, Lo; Sica, V; Lerman, A; Tajana, Gianfranco; DE NIGRIS, F. | |
| Nitric oxide induced Endoplasmic Reticulum Stress activates the expression of cargo receptor proteins and alters the glycoprotein transport to the Golgi complex | 1-gen-2006 | Renna, Maurizio; Bonatti, S; DE STEFANO, D; Carnuccio, R; Tajana, Gianfranco; Remondelli, Paolo | |
| Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis inrat carrageenin-sponge implant model | 1-gen-2004 | Maiuri, Mc; Tajana, Gianfranco; Iuvone, T; DE STEFANO, D; Mele, G; Ribecco, Mt; Cinelli, Mp; Romano, Mf; Turco, Maria Caterina; Carnuccio, R. | |
| Promotion of behavioural change in people with hypertension: an interventionstudy. | 1-gen-2008 | Scala, D; D'Avino, M; Cozzolino, S; Mancini, A; Andria, B; Caruso, G; Tajana, Gianfranco; Caruso, D. | |
| Protective role of nuclear factor kappa B against nitric oxide-induced apoptosis in J774 macrophages. | 1-gen-2001 | D'Acquisto, F; DE CRISTOFARO, F; Maiuri, Mc; Tajana, Gianfranco; Carnuccio, R. | |
| RUOLO DELL'ACIDO IALURONICO | 1-gen-1999 | Tajana, Gianfranco | |
| SISTEMA ERITROPOIETINA: LA REGOLAZIONE DEL LIFESPAN | 1-gen-2005 | Tajana, Gianfranco | |
| The immunomodulatory protein SV-IV protects serum-deprived cells againstapoptosis but not against G0/G1 arrest: possible implications for the survival ofimplanting embryo. | 1-gen-2007 | Morelli, F; Peluso, G; Petillo, O; Giannattasio, A; Filosa, S; Motta, Cm; Tammaro, S; Zatterale, A; Calzone, R; Budillon, A; Cartenì, M; DE MARIA, S; Costanza, Mr; Nigro, A; Petrazzuolo, M; Buommino, E; Rizzo, M; Capasso, G; Baiano, S; Moscatiello, F; Ravagnan, G; Fuggetta, Mp; Tajana, Gianfranco; Stiuso, P; Metafora, Bm; Metafora, V; Metafora, S. |